Join this key group of experts in early March to review what is considered to be cutting-edge in bioinformatics analysis. Discussion will include:
- reconstruction of tumour sub-clonal evolution from mutation data;
- detection and interpretation of genomic structural rearrangements;
- discovery of driver mutations and pathways;
- pathogen detection in tumour sequencing data;
- genomics analysis standards; and
- evaluation of classifier performance in the context of machine learning
High calibre national and international speakers include:
- Dr Jüri Reimand - Principal Investigator, Computational Biology Program, Ontario Institute for Cancer Research and Assistant Professor, Department of Medical Biophysics, University of Toronto
- Prof Melissa Southey, Director of Monash University’s new Biobanking Victoria initiative, Monash Health Translation Precinct and Research Director of the Monash Partners Comprehensive Cancer Consortium
- Dr Daniel Brewer - Senior Lecturer in Translational Bioinformatics, Norwich Medical School, University of East Anglia, Norwich, UK
- A/Prof Joachim Weischenfeldt – A/Prof and Group Leader at BRIC, University of Copenhagen and Rigshospitalet, Denmark and Head of Cancer Genomics, Department of Urology, Charité University Hospital
- Dr David Wedge - Group Leader in Cancer Genomics, Big Data Institute, University of Oxford
The forum will be relevant to researchers and clinicians with an interest in cancer genomics analysis, particularly with regard to the application of bioinformatics tools and techniques. The program will conclude with networking and refreshments.
Full program will be available to download soon.
Can't attend in person? Register for Webinar